This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Dumbest Things on Wall Street This Week: April 19

Stocks in this article: CXW HLF CCL

4. Ramey's Ridiculous Reversal

Note to competitive Twister players. Steer clear of D.A. Davidson analyst Tim Ramey.

Forget spineless, the guy has no skeletal system at all!

In a stunningly quick about face, Ramey said he was upgrading Herbalife (HLF - Get Report) from neutral to buy last Friday and "reestablishing" his price target on the embattled supplement seller to $78 from $38. The head-turning move came a mere three days following the longtime Herbalife bull's decision to downgrade the stock over concerns about the company's exposure to the KPMG insider trading scandal.

"Earlier this week we downgraded shares of Herbalife to Neutral from Buy, concerned that the withdrawal of KPMG's audit opinions for the past three years could have material negative impacts on the shares. After our action, the company made assurances that they did not see the risk of a delisting notice from the NYSE, nor do they believe they are, or expect they may be, in violation of their loan covenants," wrote Ramey, adding that he was "relieved to have these assurances" from Herbalife.

"Relieved"? Why is that Timmy-boy? We know we've asked you this before, but are you distributing Herbalife on the side? Otherwise, there is no plausible reason save insanity for a Wall Street analyst to be this unabashedly upbeat about such a controversial company unless investment banking fees were at stake . . . and even by those standards you've gone overboard!

"Chalk it up to the heat of battle. These are unique circumstances," wrote Ramey about his embarrassing to-ing and fro-ing.

Get a grip Tim. That "battle" talk is so ridiculous. This silly fight over a highly questionable stock is between a pair of hubristic hedge fund billionaires named Icahn and Ackman. Normandy it's not.

As for the stock, Herbalife closed slightly above $38 last Thursday night prior to Ramey's reversal. It finished down almost 4.5% Monday at $35.75.

In other words, Ramey could have saved his shareholders a fair bit of money -- and us a whole of whiplash -- if he could have only held out a full business week before changing his tune. Again.

2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs